Forge Artisan Spirit, Link the World: BioLink @ CPHI & PMEC China 2025

Table of Content [Hide]

As the bellwether of the global pharmaceutical industry in 2025, CPHI & PMEC China 2025 made a grand debut with unprecedented scale and international standards, concluding successfully on June 26, 2025. On this world-renowned stage, BioLink not only demonstrated China’s masterful craftsmanship in bioprocessing but also reaffirmed its steadfast commitment to accelerating the deep integration of Chinese pharmaceuticals with the global market through concrete actions.

CPHI_&_PMEC-1.jpg

Figure 1: BioLink Booth at CPHI & PMEC China 2025

1/ Deeper Global Connectivity, Stronger Trust Bonds

Overseas clients kept pouring into BioLink’s booth. This year, it was not only a reunion with old friends but also a gathering of new acquaintances. China’s “intelligent” manufacturing is demonstrating unprecedented charm, attracting friends from around the world to join our ever-growing global circle. During the exhibition, we had frequent interactions with these partners, showcasing efficient and pragmatic cooperation, further deepening our strategic mutual trust, and laying a solid foundation for broader cooperation in the future.

CPHI_&_PMEC-2.jpg

Figure 2: BioLink Booth Draws Numerous Global Clients

2/ Cutting-edge Products in Spotlight, Chief Scientist’s Innovative Insights

On Day 2 of the exhibition, Dr. Lin Chen, Chief Scientist of BioLink, accepted a live broadcast interview from Ouryao, a well-known media platform in pharmaceutical Industry.

CPHI_&_PMEC-3.jpg

Click to Watch Dr. Lin Chen’s Interview

Figure 3: Live Broadcast Scene of Dr. Lin Chen

Dr. Chen emphasized that BioLink is one of China’s few leading suppliers capable of providing core bioprocessing equipment, critical consumables, and integrated services. He particularly highlighted two innovative products making their debut:

1. HydroLinX® Antifoam Emusion

The product embodies over a year of BioLink’s independent R&D efforts, leveraging our mature production line of hydration product and extensive expertise in single-use system manufacturing and sterilization validation. Strictly compliant with pharmacopoeia standards, the product, when paired with BioLink’s CytoLinX® bioreactors, delivers efficient foam control during cell culture process, significantly enhancing cultivation stability and target product yield. This integrated solution truly enables customers to feel at ease, be confident, and stay worry-free.

CPHI_&_PMEC-5.jpg

Figure 4: HydroLinX® Antifoam Emusion

2. ReadyLinX® Chromatography Solution

Dr. Lin Chen vividly illustrated the core value of the solution with a “culinary” metaphor—just as delicious dishes rely on a stove, cookware, ingredients, and seasonings. In protein purification, the chromatography system serves as the “stove,” the chromatography column as the “cookware,” the chromatography resin as the essential “ingredient,” and the buffer as the “seasoning.” BioLink can provide corresponding supporting products according to different process requirements “recipes,” empowering customers to quickly become “master chefs” in protein purification, skillfully mastering the techniques and effortlessly achieving “Buffer Ready, Purity Handy.”

Figure 5: ReadyLinX® Chromatography Solution

3/ Driving Cost Reduction and Efficiency, Empowering Industry Upgrading

At the “Antibody Drug Production Capacity Building Seminar” held alongside the exhibition, Ms. Cuiling Song, Senior Application Director of BioLink, delivered an excellent speech Antibody Drug Bioprocess Considerations and Application Cases Sharing. She clearly emphasized that introducing innovative technologies and accelerating the localization of key equipment and consumables are currently the core approaches to achieving significant cost reduction and efficiency improvement. Ms. Song substantiated this with detailed cases, showing that through the domestic substitution of core materials such as culture media, single-use consumables, and chromatography resins, enterprises can achieve up to approximately 70% cost savings, injecting strong momentum into the sustainable development of the biopharmaceutical industry.

Figure 6, 7: Cuiling Song, Senior Application Director of BioLink, delivers a speech

At BioLink, high standards are a constant self-requirement. This spirit of proactive self-discipline stems from a strong sense of mission to drive the rise of China’s intelligent manufacturing and is deeply rooted in the vision of improving global health and well-being. BioLink firmly believes that only through continuous self-motivation, rapid technological iteration, and the advancement of intelligent manufacturing capabilities can the foundation of China’s upstream biopharmaceutical supply chain be truly solidified. This will not only accelerate the high-quality development of China’s biopharmaceutical industry, but also enable innovations from China to benefit the world, improving global access to medicines and contributing to the grand vision of a shared community of human health. BioLink, with its innovative processes embodying craftsmanship and a global vision promoting mutual success, keeps moving forward, contributing Chinese wisdom and strength to the future of global biomedicine.

Exhibit Express

Figure 8: BioLink Exhibits Highlights

Event Highlights

References

Popular Bioprocessing Products

IMAC Chromstar<sup>®</sup> Affinity Chromatography Resins

IMAC Chromstar^® Affinity Chromatography Resins

Chrom-LinX<sup>®</sup> Manual Compression Chromatography Column

Chrom-LinX^® Manual Compression Chromatography Column

CytoLinX<sup>®</sup> BRTF Single-use Top-driven Bioreactor Bag

CytoLinX^® BRTF Single-use Top-driven Bioreactor Bag

Link With Us Now!

Want to know more about BioLink bioprocessing products? Feel free to contact BioLink now!

Email

info@biolink.com

Phone

+86-400-058-9000

ADDRESS

New Product | FiltraLinX<sup>®</sup> Benchtop Manual Hollow Fiber TFF System

03 Jun 2024